1277227

Ultragenyx Pharmaceutical Inc. — FEI 3012208691

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 17, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Novato, CA (United States)